Cargando…

Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada

The Burkholderia cepacia complex is an important group of pathogens in patients with cystic fibrosis (CF). Although evidence for patient-to-patient spread is clear, microbial factors facilitating transmission are poorly understood. To identify microbial clones with enhanced transmissibility, we eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Speert, David P., Henry, Deborah, Vandamme, Peter, Corey, Mary, Mahenthiralingam, Eshwar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2002
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369581/ https://www.ncbi.nlm.nih.gov/pubmed/11897071 http://dx.doi.org/10.3201/eid0802.010163

Ejemplares similares

Environmental Burkholderia cepacia Complex Isolates from Human Infections
por: Baldwin, Adam, et al.
Publicado: (2007)

Diversity of the parB and repA genes of the Burkholderia cepacia complex and their utility for rapid identification of Burkholderia cenocepacia
por: Drevinek, Pavel, et al.
Publicado: (2008)

Burkholderia cepacia complex in Indian cystic fibrosis patients
por: Gautam, Vikas, et al.
Publicado: (2012)

Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex
por: Fraser-Pitt, Douglas, et al.
Publicado: (2016)

Swimming Motility in a Longitudinal Collection of Clinical Isolates of Burkholderia cepacia Complex Bacteria from People with Cystic Fibrosis
por: Zlosnik, James E. A., et al.
Publicado: (2014)

Burkholderia cepacia complex: clinical course in cystic fibrosis patients
por: Folescu, Tania Wrobel, et al.
Publicado: (2015)

Commercial use of Burkholderia cepacia.
por: LiPuma, J J, et al.
Publicado: (1999)

Can Early Burkholderia cepacia Complex Infection in Cystic Fibrosis be Eradicated with Antibiotic Therapy?
por: Horsley, Alex, et al.
Publicado: (2011)

Polyphasic characterisation of Burkholderia cepacia complex species isolated from children with cystic fibrosis
por: Vicenzi, Fernando José, et al.
Publicado: (2016)

Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients
por: Garcia, Bryan A., et al.
Publicado: (2018)

Burkholderia cepacia Complex Taxon K: Where to Split?
por: Depoorter, Eliza, et al.
Publicado: (2020)

Burkholderia cepacia complex and limited cutaneous vasculitis in patients with cystic fibrosis: a case series
por: Kayria, Muttardi, et al.
Publicado: (2017)

Biofilm-Grown Burkholderia cepacia Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species
por: Van Acker, Heleen, et al.
Publicado: (2013)

A Case Report of Cystic Fibrosis Complicated by Burkholderia Cepacia and Cutaneous Vasculitis
por: Klimko, Artsiom, et al.
Publicado: (2020)

Burkholderia cepacia infection in a non-cystic fibrosis patient: an arcane presentation
por: Ibrahim, Sufyan, et al.
Publicado: (2021)

Draft Genome Sequences of Burkholderia contaminans, a Burkholderia cepacia Complex Species That Is Increasingly Recovered from Cystic Fibrosis Patients
por: Bloodworth, Ruhi A. M., et al.
Publicado: (2015)

Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis
por: Kitt, H., et al.
Publicado: (2016)

Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem
por: Narayanaswamy, Vidya P., et al.
Publicado: (2017)

Eradication of Burkholderia cepacia complex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole
por: Akkerman-Nijland, Anne M., et al.
Publicado: (2023)

Examining the activity of cefepime-taniborbactam against Burkholderia cepacia complex and Burkholderia gladioli isolated from cystic fibrosis patients in the United States
por: Mojica, Maria F., et al.
Publicado: (2023)

Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update
por: Devanga Ragupathi, Naveen Kumar, et al.
Publicado: (2019)

Reclassification of the Specialized Metabolite Producer Pseudomonas mesoacidophila ATCC 31433 as a Member of the Burkholderia cepacia Complex
por: Loveridge, E. Joel, et al.
Publicado: (2017)

Long-Term Colonization of the Cystic Fibrosis Lung by Burkholderia cepacia Complex Bacteria: Epidemiology, Clonal Variation, and Genome-Wide Expression Alterations
por: Coutinho, Carla P., et al.
Publicado: (2011)

Serum Susceptibility in Clinical Isolates of Burkholderia Cepacia Complex Bacteria: Development of a Growth-Based Assay for High Throughput Determination
por: Zlosnik, James E. A., et al.
Publicado: (2012)

In Vitro Activity of a Novel Glycopolymer against Biofilms of Burkholderia cepacia Complex Cystic Fibrosis Clinical Isolates
por: Narayanaswamy, Vidya P., et al.
Publicado: (2019)

Evaluation of Three Culture Media for Isolation of Burkholderia cepacia Complex from Respiratory Samples of Patients with Cystic Fibrosis
por: Marrs, Emma C. L., et al.
Publicado: (2021)

Identification and molecular epidemiology of nosocomial outbreaks due to Burkholderia cepacia in cystic fibrosis patients of Masih Daneshvary Hospital, Iran
por: SOLTAN DALLAL, M.M., et al.
Publicado: (2014)

Identification of two distinct phylogenomic lineages and model strains for the understudied cystic fibrosis lung pathogen Burkholderia multivorans
por: Parfitt, Kasia M., et al.
Publicado: (2023)

Burkholderia cepacia infection in children without cystic fibrosis: a clinical analysis of 50 cases
por: Shi, Huixuan, et al.
Publicado: (2023)

Intrinsic Resistance of Burkholderia cepacia Complex to Benzalkonium Chloride
por: Ahn, Youngbeom, et al.
Publicado: (2016)

Influence of Neutrophil Defects on Burkholderia cepacia Complex Pathogenesis
por: Porter, Laura A., et al.
Publicado: (2011)

Advances in Phage Therapy: Targeting the Burkholderia cepacia Complex
por: Lauman, Philip, et al.
Publicado: (2021)

Burkholderia cepacia, cystic fibrosis and outcomes following lung transplantation: experiences from a single center in Brazil
por: de Souza Carraro, Danila, et al.
Publicado: (2018)

Burkholderia cepacia Complex Species Differ in the Frequency of Variation of the Lipopolysaccharide O-Antigen Expression During Cystic Fibrosis Chronic Respiratory Infection
por: Hassan, A. Amir, et al.
Publicado: (2019)

66 Incidence of Burkholderia cepacia complex infection in a Cystic Fibrosis Centre in Buenos Aires City, Argentina, from 2004 to 2014
por: Ibarra, L., et al.
Publicado: (2015)

Cefiderocol to manage chronic, multi-drug-resistant Burkholderia cepacia complex infection in a patient with cystic fibrosis: a case report
por: Nye, Clemency, et al.
Publicado: (2022)

Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum
por: Drevinek, Pavel, et al.
Publicado: (2008)

Antibacterial Activity of a Natural Clay Mineral against Burkholderia cepacia Complex and Other Bacterial Pathogens Isolated from People with Cystic Fibrosis
por: Behroozian, Shekooh, et al.
Publicado: (2023)

Burkholderia Cepacia Endophthalmitis: An Unusual Presentation
por: Deka, Amarendra, et al.
Publicado: (2018)

Emergence of Burkholderia cepacia in ICU Setting
por: Meena, Suneeta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_78m3au0tl3k28c8piue9gduphh